This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pust, B. Articles by Surlan, M. Search for Related Content PubMed PubMed Citation Articles by Pust, B. Articles by Surlan, M. Social Bookmarking                         What's this?

Pre-PTCA Detection of Chronic But Reversible Postischemic Myocardial Dysfunction by Nicardipine

University Clinical Center VII, Ljubljana, Slovenia. Supported by the Ministry for Science and Technology of Slovenia.

Milos Surlan, MD, PhD

University Clinical Center VII, Ljubljana, Slovenia. Supported by the Ministry for Science and Technology of Slovenia.

The aim of the study was to find out whether in patients (n = 24) with one-vessel coronary artery disease, reversibility of related left ventricular (LV) wall motion abnor malities after successful percutaneous transluminal coronary angioplasty (PTCA) can be predicted by the immediate effect of calcium antagonist nicardipine.

Dynamic quantitative left cineventriculography performed four times successively (as the control, 30 minutes after oral nicardipine, 10 minutes after PTCA, and 6 months after PTCA) and hemiaxis method (mean relative hemiaxis shortening or Xr %) were used for wall motion analysis of 48 poststenotic LV myocardial segments divided into three groups: hypokinetic noninfarcted (PNHS, n = 25), infarcted (PIS, n = 12), and normokinetic noninfarcted (PNNS, n =11) and of 24 normal LV myocardial segments (NS).

In PNHS and PIS close correlation (r = 0.75, P < 0.0001 and r = 0.71, P < 0.005) was demonstrated between postnicardipine improvement (21 ±4% to 37 ±9%, P < 0.0001, and 16 ±7% to 20 ±8%, P < 0.0005) and 6 months after PTCA improvement (21 ±4% to 33 ± 7%, P < 0.0001, and 16 ± 7% to 19 ± 9%, P < 0.0005) of wall motion. It was loose in PNNS and absent in all three groups immediately after PTCA. The sensitivity of the nicardipine test for 6 months after PTCA reversible LV segmental hypokinesia was high in PNHS (95%) and lower in PIS and PNNS (67% and 60%, respectively). The speci- ficity was 100% in PIS, lower in PNNS (67%), and absent in PNHS (owing to lack of true nonresponders). Immediately after PTCA, contraction significantly improved only in PNHS; the nicardipine test was 100% sensitive but nonspecific.

Significant improvement of contraction of all groups of poststenotic LV wall segments is expected 6 months after successful PTCA of related artery stenosis, being well predictable by the pre-PTCA effect of nicardipine, at least in PNHS and in PIS. Immediate ly after PTCA, only in PNHS can significant improvement of contraction be expected.

Angiology, Vol. 49, No. 2, 115-127 (1998)
DOI: 10.1177/000331979804900204


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?